Business Wire

Vecima Acquires Falcon V Systems, Provider of Innovative Software Orchestration Platform for Cable, Fiber, and Mobile Access Networks

11.10.2024 13:30:00 CEST | Business Wire | Press release

Share

Combination of Vecima’s Entra Cloud™ and Falcon’s Principal Core and Test Suite will help operators accelerate and simplify cable, fiber, and mobile access network and service flow convergence, using automated software tools and testing Charter Communications will be the initial customer, signing a multi-year deal to deploy both the Principal Core and Test Suite Falcon V Systems’ open, interoperable platform supports multiple vendors’ vCMTS platforms, including Vecima’s Entra® vCMTS & Entra® vPON Manager

Vecima Networks, Inc. (TSX: VCM) today announced that, through its subsidiary Vecima Technology B.V., it has acquired Falcon V Systems, a Poland-based provider of vendor-agnostic, virtualized software solutions and services for Broadband Service Providers worldwide.

Vecima has acquired all outstanding Falcon V Systems shares, as well as the company’s technology, intellectual property, and talent. With the close of the acquisition today, Vecima will onboard a significant portion of the Falcon V team which will be integrated into Vecima’s Video & Broadband Solutions business, comprising its market-leading Entra broadband access portfolios and talent.

Falcon V Systems’ key products will be integrated into Vecima’s Entra Cloud™ portfolio of open, interoperable, cloud-native applications that help cable operators transform their networks for next-generation broadband access:

  • Falcon V Systems’ Principal Core manages across multiple cable, fiber, and mobile cores, allowing a multivendor environment, with seamless integration across the OSS/BSS ecosystem — a convergence of services not possible previously.

  • The Test Suite is a comprehensive set of tools, focused on helping Broadband Service Providers accelerate deployments and feature enhancements, through an automated, end-to-end test environment.

“I’m incredibly proud of what the Falcon V team has accomplished, and I extend my sincerest thanks to our talented Falcon team, our partners, and our customers,” said Ulf Andersson, CEO of Falcon V Systems. “Vecima will take our work forward and bring it to market on a global scale, unlocking the potential of the Falcon V technology and team.”

“Our work over the last several years with Falcon V Systems has been a critical component in our long-term access architecture strategy, enabling us to simplify and enhance the subscriber experience,” said Justin Colwell, Executive Vice President, Connectivity Technology, Charter Communications. “We plan to deploy the Principal Core, which will be a component of Vecima’s vCMTS solution, along with the Test Suite, and look forward to working closely with Vecima to lead wider adoption of the Entra Cloud platform across the industry.”

“Flexibility and interoperability are the cornerstone of Vecima’s unique approach to access networks and the hallmark of Falcon V Systems’ automation and orchestration software,” said Clay McCreery, Chief Operating Officer at Vecima. “With this acquisition, Vecima expands its research and development footprint into Europe with an expert team of DAA technologists in Poland. Falcon V Systems will be able to take advantage of Vecima’s global scale, existing vCMTS and PON platforms, and extensive customer relationships.”

“Vecima’s mission is to empower service providers globally with the transformative solutions that usher in the new multi-gigabit connectivity era to come,” said Sumit Kumar, Vecima President and Chief Executive Officer. “We are embarking on a new phase of growth, and by adding the Falcon V Systems team and technology to our expansive industry-leading broadband access portfolio, we broaden, once more, our ability to meet the evolving network convergence needs of Broadband Service Provider customers worldwide. With the Falcon team & Charter’s long-term partnership, this acquisition further deepens Vecima’s leadership in the Broadband Service Provider segment.”

About Falcon V Systems

Falcon V Systems is an independent challenger that delivers a cost-effective, scalable, and non-proprietary open DAA solution for Broadband Service Providers based on Software Defined Networking (SDN) and Network Functions Virtualization (NFV). This non-monolithic, agile architecture will enable more efficient use of network assets, data centers, and cloud assets. Thanks to open interfaces, the solution evolves along with the growth of needs and supports the cooperation between operators and other vendors.

About Vecima Networks

Vecima Networks Inc. (TSX: VCM) is leading the global evolution to the multi-gigabit, content-rich networks of the future. Our talented people deliver future-ready software, services, and integrated platforms that power broadband and video streaming networks, monitor and manage transportation, and transform experiences in homes, businesses, and everywhere people connect. We help our customers evolve their networks with cloud-based solutions that deliver ground-breaking speed, superior video quality, and exciting new services to their subscribers. There is power in connectivity – it enables people, businesses, and communities to grow and thrive. Learn more at vecima.com.

Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws. Forward-looking information is generally identifiable by use of the words “believes”, “may”, “plans”, “will”, “anticipates”, “intends”, “could”, “estimates”, “expects”, “forecasts”, “projects” and similar expressions, and the negative of such expressions.

Forward-looking information in this news release includes, but is not limited to, any statements respecting: Vecima will onboard a significant portion of the Falcon V team which will be integrated into Vecima’s Video & Broadband Solutions business; closing of the transaction will allow Vecima to expand its research and development footprint into Europe; Falcon V Systems’ key products will be integrated into Vecima’s Entra Cloud™ portfolio; Charter Communications’ plans to deploy the Principal Core and Test Suite.

The forward-looking statements are based on the current expectations of the management of Vecima and are inherently subject to uncertainties and changes in circumstances and their potential effects and speak only as of the date of such statement. There can be no assurance that future developments will be those that have been anticipated.

A more complete discussion of the risks and uncertainties facing Vecima is generally disclosed under the heading “Risk Factors” in the Company’s Annual Information Form dated September 19, 2024, as well as the Company’s continuous disclosure filings with Canadian securities regulatory authorities available at www.sedarplus.ca. All forward-looking information herein is qualified in its entirety by this cautionary statement, and Vecima disclaims any obligation to revise or update any such forward-looking information or to publicly announce the result of any revisions to any of the forward-looking information contained herein to reflect future results, events, or developments, except as required by law.

View source version on businesswire.com: https://www.businesswire.com/news/home/20241010671688/en/

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Backed by Investments Exceeding $1 Billion, PCI Pharma Services Announces Major Expansion of US Sterile Fill-Finish and Drug-Device Delivery Combination Capabilities27.4.2026 16:00:00 CEST | Press release

As pharma manufacturers prioritize US supply chain resilience, highlights include high-speed isolator filling lines for prefilled syringes, cartridges and vials, and drug-device combination assembly and packaging. PCI Pharma Services (“PCI”) – a world-leading integrated global contract development and manufacturing organization (CDMO) focused on innovative biologic and small molecule therapies – announced a series of major infrastructure investments that substantially deepen its sterile fill-finish and advanced drug delivery capabilities. As pharma manufacturers and their development partners increasingly prioritize US supply chain resilience, PCI’s latest investments come as part of a broader commitment exceeding $1 billion across the CDMO’s US and European operations, reinforcing its ability to provide seamless support for drug product development and manufacturing, clinical trial supply and drug-device combination assembly from clinical stages through commercial launch – all underpi

Pure Lithium Appoints Renowned Battery Expert Dr. Yuan Gao to Board of Directors27.4.2026 15:53:00 CEST | Press release

Pure Lithium Corporation, a vertically integrated lithium metal battery technology company, is pleased to announce that world-renowned inventor and battery expert Dr. Yuan Gao has joined the company’s Board of Directors. Dr. Gao has been an invaluable member of Pure Lithium’s Scientific Advisory Board since October of 2023. "We are thrilled to have Dr. Gao join our board as we focus on rapidly scaling our technology in the most capital efficient manner possible,” said Pure Lithium Founder, Chairman and CEO Emilie Bodoin. “Dr. Gao is a brilliant scientist who also has deep commercial expertise, a rare combination. He is also unique in the industry because his experience spans the entire battery materials value chain, including all of Pure Lithium’s verticals. His insights over the years have been critical in advancing our technology, and his experience as a director of public companies will strengthen our board.” Dr. Gao commented: “I am thrilled to join the board of Pure Lithium Corpor

Taiho Oncology, Taiho Pharmaceutical and Araris Biotech AG Advance ADC ARC-02 into Phase 1 Clinical Development27.4.2026 15:00:00 CEST | Press release

Phase 1 dose-escalation trial represents the first clinical trial of a product developed using the AraLinQ™ ADC technology and marks Taiho’s expansion into the clinical development of ADCs for oncology Taiho Oncology, Inc., Taiho Pharmaceutical Co., Ltd., and Araris Biotech AG (“Araris”) today announced that the U.S. Food and Drug Administration (FDA) has completed its Investigational New Drug (IND) review period for ARC-02, an antibody-drug conjugate (ADC) being developed for the treatment of non-Hodgkin lymphoma, enabling Taiho Oncology to initiate a Phase 1 dose-escalation clinical trial of ARC-02. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427127507/en/ Taiho Pharmaceutical acquired Araris Biotech in March 2025, expanding Taiho group’s capabilities in biologics and ADC research and development. Araris is a spin-off of the Paul Scherrer Institute and ETH in Switzerland focused on the development of antibody-drug co

Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 202627.4.2026 15:00:00 CEST | Press release

Premier global event to highlight how organizations are bringing data to life to power everything from AI to BI Boomi, the data activation company, today announced Boomi World 2026, its premier annual user conference, taking place May 11 - 14, 2026 in Chicago, IL. The event will bring together customers, partners, and industry leaders from around the world to explore how data activation is transforming the enterprise and accelerating the path to AI-driven outcomes. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427600340/en/ Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 2026 Boomi World 2026 will spotlight data activation — bringing data to life to power AI, analytics, and intelligent automation. Attendees will gain firsthand insights into how the Boomi Enterprise Platform enables businesses to unify data, streamline operations, and innovate faster in an increasingly agentic world.

Axinn Appoints Rachael Philbin as Chief Innovation Officer27.4.2026 15:00:00 CEST | Press release

Appointment Reflects Firm's Vision for the Future of Legal Practice Axinn, Veltrop & Harkrider LLP today announced the appointment of Rachael Philbin as Chief Innovation Officer, reinforcing the firm’s continued investment in advanced solutions and technology for legal services delivery. Philbin joins from Proskauer Rose LLP, where she served as Innovation & Transformation Officer. Based in Axinn's New York office, she will lead the firm’s AI and legal technology initiatives as well as knowledge management efforts, accelerating adoption and integration across its antitrust, intellectual property, and litigation practices. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427277725/en/ Rachael Philbin joins Axinn, Veltrop & Harkrider LLP as Chief Innovation Officer. “As Axinn continues to grow, we are making deliberate investments in the capabilities that enable our lawyers to deliver service and results at the highest level

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye